A detailed history of First Horizon Advisors, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 349 shares of GKOS stock, worth $50,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
349
Previous 349 -0.0%
Holding current value
$50,322
Previous $41,000 9.76%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

BUY
$34.86 - $63.77 $12,166 - $22,255
349 New
349 $15,000
Q1 2022

May 10, 2022

SELL
$44.33 - $57.82 $15,471 - $20,179
-349 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $15,462 - $27,458
326 Added 1417.39%
349 $16,000
Q3 2021

Nov 09, 2021

SELL
$47.43 - $84.23 $15,462 - $27,458
-326 Reduced 93.41%
23 $1,000
Q2 2021

Aug 09, 2021

BUY
$73.06 - $97.7 $25,497 - $34,097
349 New
349 $29,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.86B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.